208 related articles for article (PubMed ID: 32808286)
41. The Australian Mohs database, part II: periocular basal cell carcinoma outcome at 5-year follow-up.
Malhotra R; Huilgol SC; Huynh NT; Selva D
Ophthalmology; 2004 Apr; 111(4):631-6. PubMed ID: 15051193
[TBL] [Abstract][Full Text] [Related]
42. Basal cell carcinoma treated with Mohs surgery in Australia III. Perineural invasion.
Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
J Am Acad Dermatol; 2005 Sep; 53(3):458-63. PubMed ID: 16112353
[TBL] [Abstract][Full Text] [Related]
43. Mohs micrographic surgery for basal cell carcinomas: results of a Spanish retrospective study and Kaplan–Meier survival analysis of tumour recurrence.
Català A; Garces JR; Alegre M; Gich IJ; Puig L
J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1363-9. PubMed ID: 25383396
[TBL] [Abstract][Full Text] [Related]
44. Basosquamous carcinoma and metatypical basal cell carcinoma: a review of treatment with Mohs micrographic surgery.
Allen KJ; Cappel MA; Killian JM; Brewer JD
Int J Dermatol; 2014 Nov; 53(11):1395-403. PubMed ID: 24961583
[TBL] [Abstract][Full Text] [Related]
45. Clinicopathological factors influencing the number of stages of Mohs surgery for basal cell carcinoma.
Calvão J; Pinho A; Brinca A; Vieira R
An Bras Dermatol; 2022; 97(3):291-297. PubMed ID: 35379511
[TBL] [Abstract][Full Text] [Related]
46. Residual skin cancer after preoperative biopsy: evaluation by Mohs micrographic surgery.
Alcalay J; Alkalay R; Hazaz B
Int J Dermatol; 2004 Jun; 43(6):456-8. PubMed ID: 15186232
[TBL] [Abstract][Full Text] [Related]
47. Detection of High-Risk Histologic Features and Tumor Upstaging of Nonmelanoma Skin Cancers on Debulk Analysis: A Quantitative Systematic Review.
Singh B; Dorelles A; Konnikov N; Nguyen BM
Dermatol Surg; 2017 Aug; 43(8):1003-1011. PubMed ID: 28654579
[TBL] [Abstract][Full Text] [Related]
48. Factors affecting choice of repair in Mohs micrographic surgery for non-melanoma skin cancer of the head.
Thomas CL; Lam A; Lam J; Paver R; Storey L; Fernandez-Peñas P
Australas J Dermatol; 2017 Aug; 58(3):189-193. PubMed ID: 26914474
[TBL] [Abstract][Full Text] [Related]
49. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia II. Perineural invasion.
Leibovitch I; Huilgol SC; Selva D; Hill D; Richards S; Paver R
J Am Acad Dermatol; 2005 Aug; 53(2):261-6. PubMed ID: 16021121
[TBL] [Abstract][Full Text] [Related]
50. Mohs appropriate use criteria: retrospectively applied to nonmelanoma skin cancers at a single academic center.
Chong T; Tristani-Firouzi P; Bowen GM; Hadley ML; Duffy KL
Dermatol Surg; 2015 Aug; 41(8):889-95. PubMed ID: 26066619
[TBL] [Abstract][Full Text] [Related]
51. Squamous Cell Carcinoma In Situ Upstaged to Invasive Squamous Cell Carcinoma: A 5-Year, Single Institution Retrospective Review.
Eimpunth S; Goldenberg A; Hamman MS; Oganesyan G; Lee RA; Hunnangkul S; Song SS; Greywal T; Jiang SIB
Dermatol Surg; 2017 May; 43(5):698-703. PubMed ID: 28060173
[TBL] [Abstract][Full Text] [Related]
52. Management of periocular basal and squamous cell carcinoma: a series of 485 cases.
Nemet AY; Deckel Y; Martin PA; Kourt G; Chilov M; Sharma V; Benger R
Am J Ophthalmol; 2006 Aug; 142(2):293-7. PubMed ID: 16876511
[TBL] [Abstract][Full Text] [Related]
53. Curettage prior to Mohs' micrographic surgery for previously biopsied nonmelanoma skin cancers: what are we curetting? Retrospective, prospective, and comparative study.
Jih MH; Friedman PM; Goldberg LH; Kimyai-Asadi A
Dermatol Surg; 2005 Jan; 31(1):10-5. PubMed ID: 15720088
[TBL] [Abstract][Full Text] [Related]
54. Perianal basal cell carcinoma treated with Mohs micrographic surgery.
Ryan M; Alabdulrazzaq H; Toyohara J
Cutis; 2018 May; 101(5):362;365;366. PubMed ID: 29894525
[TBL] [Abstract][Full Text] [Related]
55. Imiquimod 5% cream as pretreatment of Mohs micrographic surgery for nodular basal cell carcinoma in the face: a prospective randomized controlled study.
van der Geer S; Martens J; van Roij J; Brand E; Ostertag JU; Verhaegh ME; Neumann HA; Krekels GA
Br J Dermatol; 2012 Jul; 167(1):110-5. PubMed ID: 22385074
[TBL] [Abstract][Full Text] [Related]
56. Mohs micrographic surgery referral patterns: the University of Missouri experience.
Gaston DA; Naugle C; Clark DP
Dermatol Surg; 1999 Nov; 25(11):862-6; discussion 866-7. PubMed ID: 10594598
[TBL] [Abstract][Full Text] [Related]
57. A systematic review of the incidence of basal cell carcinoma with perineural invasion: conventional pathology versus Mohs micrographic surgery.
Hill MJ; Hoegler KM; Zhou AE; Snow CR; Khachemoune A
Arch Dermatol Res; 2023 Mar; 315(2):127-132. PubMed ID: 35467131
[TBL] [Abstract][Full Text] [Related]
58. Appropriate use criteria for basal cell carcinoma Mohs surgery at a single center in the face of high-burden skin cancer: a retrospective cohort study.
Fantini BC; Bueno Filho R; Chahud F; Souza CDS
J Dermatolog Treat; 2019 Feb; 30(1):74-80. PubMed ID: 29727201
[TBL] [Abstract][Full Text] [Related]
59. Histological evaluation of residual basal cell carcinoma after shave biopsy prior to Mohs micrographic surgery.
Alcalay J; Alkalay R
J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):839-41. PubMed ID: 21054570
[TBL] [Abstract][Full Text] [Related]
60. Basal cell carcinoma treated with Mohs micrographic surgery in young Ibero-American patients.
Aluma-Tenorio MS; Ávila-Álvarez A; Jaimes N; Caballero-Uribe N; González A; Terzian LR; Ocampo-Candiani J; Zuluaga MA; Garza-Rodríguez V; Tamayo-Betancur MC; Cuesta-Castro DP; Garcés JR; Ruiz-Salas V; Goldberg L; Kimyai-Asadi A
Int J Dermatol; 2018 Dec; 57(12):1447-1453. PubMed ID: 30168850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
